Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3118-3157
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3118
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3118
Figure 4 Univariate and multivariate Cox proportional hazards regression analyses were used to identify prognosis-related genes.
A: Violin plots depicting the relationship between pathological grade and risk score; B: Violin plots depicting the relationship between tumor stage and risk score; C and D: Prognostic performance of risk scores based on both univariate (C) and multivariate (D) Cox regression analyses; E and F: Prognostic performance of peptidylprolyl isomerase A (PPIA) (E) and solute carrier family 29 member 3 (SLC29A3) (F) based on multivariate Cox regression analysis; G and H: Nomograms showing the relationship between various clinicopathological parameters and the expression of PPIA (G) and SLC29A3 (H); aP < 0.05, indicates a significant difference. The predicted 1-year, 3-year, and 5-year survival probabilities and the actual 1-year, 3-year, and 5-year survival probabilities are presented in the nomograms. PPIA: Peptidylprolyl isomerase A; SLC29A3: Solute carrier family 29 member 3.
- Citation: Cao Y, Li PP, Qiao BL, Li QW. Kombo knife combined with sorafenib in liver cancer treatment: Efficacy and safety under immune function influence. World J Gastrointest Oncol 2024; 16(7): 3118-3157
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3118.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3118